Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

AbbVie Inc (ABBV), PepsiCo, Inc. (PEP) & More: 5 Stocks with 40 or More Years of Dividend Increases

Page 1 of 2

Market-beating strategies are inherently hard to find. Based on the evidence from several major developed markets, dividend growth was the single largest contributor to nominal stock market returns over the past 40 years, according to Société Générale.

An exclusive club

A small group of companies pursues a policy of boosting shareholder value through consistent annual dividend increases for decades. Among the stocks with the longest streaks of consecutive dividend growth, the following five companies yielding more than 2% celebrate 40 years or more of dividend growth. Four of the featured stocks are constituents of the S&P 500 Dividend Aristocrats Index, while only one is a small-cap water utility stock.

AbbVie Inc (NYSE:ABBV)

Let’s get started

AbbVie Inc (NYSE:ABBV) is a research-based pharmaceutical company that spun off from Abbott Laboratories (NYSE:ABT) in late 2012, so it does not have its own, stand-alone historical metrics of long-term dividend growth. The new company is heavily dependent on the sales of its blockbuster immunology drug, Humira, enjoying patent protection until 2016. The drug sales still have room to grow as the drug’s growth continues to outpace the U.S. and key EU biologics markets’ growth rates. Still, the company will have to diversify its revenue base. In that regard, it has potential in several areas, developing products in late-stage trials for the treatment of hepatitis C virus, immunological diseases, multiple sclerosis, and Parkinson’s disease.

In terms of valuation, this stock is trading at 13.3x forward earnings, below its respective industry’s forward P/E of 15.2x. The stock, however, has a high price-to-book ratio. At the end of last quarter, AbbVie Inc (NYSE:ABBV) was a large new position in the portfolios of hedge fund managers Arthur B. Cohen and Joseph Healey of Healthcore Management as well as billionaire Steven Cohen of SAC Capital.

Kimberly Clark Corp (NYSE:KMB), a consumer goods giant, has grown its dividend at an average CAGR of 7.4% over the past five years. This annualized rate of dividend growth was close to the company’s rate of EPS growth, averaging 5.4%, over the past half-decade. Back in February, the company raised its dividend by 9.5%, above the noted five-year average, marking the firm’s 41st consecutive annual dividend increase. The stock has delivered strongly over the past decade at least, with its 10-year annualized total return averaging 10.2% versus 7.9% for the S&P 500 index.

The company has also delivered strong financial performance, with its overall organic sales growing 5% last year, and the international segment’s organic sales increasing 10%. Particularly robust has been growth in emerging market personal care products. Adjusted EPS grew 9% last year. It is projected to increase by 5%-to-8% this fiscal year. Aside from the market expansion, product innovation has been a key driver of growth. The company’s long-term growth prospects will largely depend on these growth drivers.

As regards its valuation, the stock is trading at 18.2x forward earnings versus 20.6x of the personal care industry. Last quarter, Kimberly-Clark was a large $191 million position in Ric Dillon’s 13F portfolio.

The best of the rest

PepsiCo, Inc. (NYSE:PEP), a snacks and soft drinks giant, has grown its dividend at an average CAGR of 8.8%, faster than its annual EPS growth of 5.7% over the same period. The company hiked its quarterly dividend by 5.6% in February, effective as of June 2013, marking the firm’s 41st annual dividend increase. Aside from dividends, PepsiCo, Inc. (NYSE:PEP) is also boosting shareholder value through share buybacks, authorizing $10 billion for the period between July 1, 2013 and June 30, 2016. In fact, this year alone, the company expects to return a total of $6.4 billion through dividends (some $3.4 billion) and share repurchases (about $3.0 billion).

Analyst forecast PepsiCo, Inc. (NYSE:PEP)’s EPS CAGR at 8.9% for the next five years, about the same as that of its archrival The Coca-Cola Company (NYSE:KO). PepsiCo, Inc. (NYSE:PEP)’s diversified product mix, including both snacks and beverages, will help it weather the weak soda sales trends in the U.S. market. Back in February, CLSA upgraded the stock to buy, citing valuation expansion expectations, higher Return on Invested Capital amid North American bottling restructuring, and forecasted earnings improvement.

Currently though, PEP is trading at a forward P/E of 18.0x, high but below the soft drinks industry’s 19.8x. Among fund managers, last quarter, the stock was popular with billionaire Donald Yacktman.

V.F. Corporation (NYSE:VFC) is a global leader in the branded apparel industry. Over the past five years, the company’s dividend grew at an average CAGR of 5.6%, slower than its EPS CAGR, averaging 16.7% over the same period. Last year, the company reported record revenues and profits, with its top line growing 15% and EPS expanding 17%, both in nominal terms. The diversity and strength of the company’s portfolio of brands is what has propelled it to record-high financial results.

The company expects somewhat slower growth this fiscal year, with revenues rising 6% for the year and EPS expanding at a projected 11%. Accounting for 37% of total sales in 2012, international revenues have been on a tear, having increased 29% last year, driven mostly by strong sales of the company’s Timberland brand, which V.F. Corporation acquired back in 2011. This year, however, sales of Timberland and North Face brands are expected to be slower.

In terms of valuation, V.F. stock is priced at 15.7x forward earnings, compared to 14.6x for apparel retailers, 14.2x for The Gap Inc. (NYSE:GPS) and 18.8x for Ralph Lauren Corp (NYSE:RL). Last quarter, Ric Dillon trimmed his V.F. share count by 5% to more than 917,000 shares, while Christopher Medlocki James boosted his share ownership by 181% to nearly 830,000 shares.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!